MétaCan
Menu
Back to cohort
Record W4412005438 · doi:10.1002/ejhf.3754

Changes in Natriuretic Peptide Levels Following Patiromer-Enabled Optimization of Medical Therapy In Heart Failure: A Post Hoc Analysis of the DIAMOND Study

2025· article· en· W4412005438 on OpenAlexaff
Andreas P. Kalogeropoulos, Ishaque Hameed, Stefan D. Anker, Antoni Bayés‐Genís, Michael Böhm, Jeffrey Budden, John G.F. Cleland, Andrew J.S. Coats, Justin A. Ezekowitz, Gerasimos Filippatos, Assen Goudev, Muhammad Shahzeb Khan, JoAnn Lindenfeld, Lars H. Lund, Béla Merkely, Robert J. Mentz, Marco Metra, Jude Moutchia, Amandine Perrin, Piotr Ponikowski, Elisa L. Priest, Patrick Rossignol, Michele Senni, Courtney Shaver, Sandra Waechter, Matthew R. Weir, Bertram Pitt, Javed Butler

Bibliographic record

VenueEuropean Journal of Heart Failure · 2025
Typearticle
Languageen
FieldMedicine
TopicPotassium and Related Disorders
Canadian institutionsSurgical Specialties (Canada)University of Alberta
FundersVifor Pharma
KeywordsMedicineHeart failureNatriuretic peptideEjection fractionClinical endpointInternal medicinePlaceboPost-hoc analysisCardiologyConfidence intervalRandomizationUrologyRandomized controlled trialPathology

Abstract

fetched live from OpenAlex

AIMS: In the DIAMOND (Patiromer for the Management of Hyperkalaemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure) trial, the potassium binder patiromer enabled optimization of renin-angiotensin-aldosterone system inhibitors (RAASi) for patients with heart failure and a reduced ejection fraction (HFrEF) and current or recent hyperkalaemia. In this post-hoc analysis, we evaluated the effect of patiromer-enabled RAASi optimization on N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels, an established surrogate endpoint for clinical outcomes in HFrEF. METHODS AND RESULTS: During screening, 539 (61.4%) of the 878 subsequently randomized patients had NT-proBNP ≥1000 pg/ml, measured prior to a 12-week run-in period on single-blinded patiromer during which RAASi were optimized. Among these patients, 165/266 (62%) in the patiromer and 172/273 (63%) in the placebo arm had follow-up NT-proBNP. For these 337 patients, we evaluated the change in NT-proBNP from screening to week 18 after randomization. NT-proBNP declined by -53% (95% confidence interval -59% to -46%; p < 0.001) in both arms combined (median absolute change: -731 [-1832, 107] pg/ml), with no significant difference between the two arms (p = 0.135). A >30% NT-proBNP reduction was observed in 93/165 (56%) patiromer and 88/172 (51%) placebo patients (p = 0.38), whereas 60/165 (36%) and 53/172 (31%), respectively, achieved NT-proBNP levels <1000 pg/ml at week 18 (p = 0.30). CONCLUSIONS: In this post-hoc analysis of DIAMOND, patients with HFrEF and elevated (>1000 ng/ml) NT-proBNP at screening experienced clinically meaningful NT-proBNP reductions following a RAASi optimization strategy that included patiromer during the run-in phase, with no significant differences observed between patiromer and placebo groups during the randomized withdrawal phase.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.044
Threshold uncertainty score0.459

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.003
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.011
GPT teacher head0.266
Teacher spread0.255 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Journal of Heart FailureSame topicPotassium and Related DisordersFrench-language works237,207